Talk:Cerivastatin

Pharmacology Mid‑importance

	This article is within the scope of WikiProject Pharmacology, a collaborative effort to improve the coverage of Pharmacology on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.PharmacologyWikipedia:WikiProject PharmacologyTemplate:WikiProject Pharmacologypharmacology articles
Mid	This article has been rated as Mid-importance on the project's importance scale.

Chemicals Low‑importance

	This article is within the scope of WikiProject Chemicals, a daughter project of WikiProject Chemistry, which aims to improve Wikipedia's coverage of chemicals. To participate, help improve this article or visit the project page for details on the project.ChemicalsWikipedia:WikiProject ChemicalsTemplate:WikiProject Chemicalschemicals articles
Low	This article has been rated as Low-importance on the project's importance scale.

Ideal sources for Wikipedia's health content are defined in the guideline Wikipedia:Identifying reliable sources (medicine) and are typically review articles. Here are links to possibly useful sources of information about Cerivastatin.

PubMed provides review articles from the past five years (limit to free review articles)
The TRIP database provides clinical publications about evidence-based medicine.
Other potential sources include: Centre for Reviews and Dissemination and CDC

This is very weak

I am not a doctor. I am from Germany and there is a lot missing.

Most important: The deaths occured not because of Lipobay itself - it happened in combination with Gemfibrozil, also a satelin.

There was a debatte if the doctors were "too stupid" to read the instructions. Above substance was mentioned and it said, it is dangerous to combine both medicaments. Seriously, which doctor prescribes a new medicament in combination with the old one without research on the possible outcome? Commercials are not enough… —Preceding unsigned comment added by Jorgusch (talk • contribs) 22:04, 2 April 2008 (UTC)[reply]

Cerivastatin revisited

As we debate potency of statins, one must historically include Cerivastatin. For many years this was the statin of choice for the US Department of Defense as well as many other plans. I personally prescribed this statin thousands of times through the 1980s ahead of lovastatin, simvastatin and atorvastatin with no regrets and no hepatic morbidity. Rosuvastatin wasn't invented yet as an intermediary. Separation of highly potent statins from Red Yeast Rice yields few best molecules as the debate unfolds. Prescribed in micrograms, this molecule is probably still useful in animal models. Statins are a sword with two edges; no one on earth has taken them before 1982 when (fungal derived) Mevacor was introduced and we are still learning about the molecular collateral damage, especially in terms of glycemic control. --lbeben 02:17, 21 November 2013 (UTC)